PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. maike.janssen@med.uni-heidelberg.de.\', \'Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.\', \'NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.\', \'Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.\', \'Division of Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.\', \'Division of Infectious Diseases, University Hospital Frankfurt, Frankfurt, Germany.\', \'University Hospital Dresden, Dresden, Germany.\', \'Charité University Medicine, Berlin, Germany.\', \'Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital, Heidelberg, Germany.\', \'Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.\', \'Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.\', \'Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany.\', \'Department of Anaesthesiology, Heidelberg University Hospital, Heidelberg, Germany.\', \'Department of Internal Medicine IV, Heidelberg University Hospital, Heidelberg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04735-y
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33023671
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all